The upstream activating sequence (UAS) conferring leucine-specific regulation of transcription in Saccharomyces cerevisiae was identified by analysis of the LEU2 promoter and by comparison to other genes regulated by leucine. The UAS was localized with deletions and cloned synthetic DNA. Point mutations and sequence rearrangements were used to identify important basepairs and to construct an improved UAS with increased regulation and expression. The improved UAS contains a core ten basepair, GC-rich, palindromic sequence, which is sufficient to confer minimal levels of activation and regulation, within a 36 basepair palindromic sequence which confers maximal activation and regulation. Deletions downstream of the UAS indicated that the UAS must act in conjunction with at least one other site, perhaps a TATAA region, in order to confer high levels of activation. Tandem copies of the UAS in front of LEU2 increased expression and regulation. Tandem UAS elements in trans on a multi-copy 2,f-based plasmid decreased expression and regulation. These results are consistent with a model that the UAS serves as the DNA-binding site for diffusible activation factor(s), possibly the LEU3 gene product.
INTRODUCTION
In Saccharomyces cerevisiae, leucine coordinately regulates the production of a number of enzymes involved in leucine, isoleucine, and valine biosynthesis. Induction of these enzymes requires a-isopropyl malate (a-IPM), a leucine precursor (1) , the LEU3 gene product (2, 3, 4, 5) and an upstream activating sequence (UAS) specific for leucine regulation (3, 4, 6) . a-IPM synthesis is reduced by leucine feedback repression of the LEU4 enzyme a-isopropyl malate synthase (1, 5, 7) , which catalyzes the first committed step in leucine biosynthesis and is responsible for the synthesis of over 80% of the cell's a-IPM (1) .
Genes regulated by leucine include the leucine biosynthetic genes LEU1 for a-isopropyl malate isomerase, LEU2 for ,B-isopropyl malate dehydrogenase, LEU4, and at least three branched-chain amino acid genes, ILV2, ILV3, and ILVS (1, 3, 4, 6, 8, 9) . For Genbank accession no. J01333
these genes, high levels of leucine in the growth media represses the genes enzymatic activities. In particular, the LEU2 enzymatic activity and mRNA levels are repressed 10-fold and approximately 5-fold (5, 10, 11, 12) , respectively. In the LEU2 promoter, a region responsible for leucine regulation was mapped to a region containing an imperfect GCrich palindrome (6) , A. Martinez-Arias and M. Casadaban, unpublished) . This regulatory region was identified as an upstream activating sequence (UAS), based on its ability to promote transcription and mediate gene-specific regulation (6, 13, 14) . The region functions in a distance-and orientationindependent fashion with respect to its downstream promoter elements (6) and confers leucine-specific regulation when it is substituted for the UAS of the gene CYCJ (6) .
The GC-rich palindromic sequence within the UAS region in LEU2 is homologous to sequences in other genes responsible for the biosynthesis of branched-chain amino acids, including LEUI (15) , LEU4 (8) , ILV2 (16) , and ILV5 (9, 17) of Saccharomyces cerevisiae, and LEU2 of Candida maltosa (18) and Yarrowia lipolytica (19) . All of these genes, except for the last one which has not been tested, are regulated by leucine in S. cerevisiae (2, 8, 9, 18) .
Here we report the characterization and optimization of the UAS for leucine regulation using deletions, point mutations, sequence rearrangements, and cloned synthetic DNA of the LEU2 gene.
MATERIALS AND METHODS
Strains, plasmids, phages, and media Relevant strains, phages, and plasmids are listed in Table 1 . The S. cerevisiae strain M12b was used to test all LEU2 promoter constructs. E. coli strains JM103, MC 1065, and MC1066TR were used to construct the various vectors and promoters. Ml3mp phages and the E. coli strain BW3 13 were used to construct the oligonucleotide-directed base changes and also for sequencing. Phage pMH14 is a recombinant containing the M13 phage sequences of M 13mp19 (20) , the polylinker sequences of M13mp9 (21) , and the LEU2 sequences from -221 to + 39 flanked by EcoRI and BamHI sites. The plasmids not listed in Table 1 are described elsewhere. * To whom correspondence should be addressed .=) 1990 Oxford University Press The bacterial and yeast media were described previously (6, 22) . Yeast minimal media (1 x yeast nitrogen base without amino acids, 2% glucose, and appropriate amino acids or nucleotide supplements) were buffered with M63 salts (23) when the colorimetric indicator 5-bromo-4-chloro-3-indolyl-13-Dgalactosidase (X-Gal) was utilized or when the yeast cells were to be assayed for /3-galactosidase expression. In order to repress the LEU2 promoter the L-amino acids leucine, threonine, isoleucine, and valine were added at a concentration of 2mM each to M63 liquid media, and leucine and threonine alone were added at concentrations ranging from 2-OmM to solid media. Repressed media was supplemented by isoleucine and valine to prevent the drop in growth caused by the addition of high concentrations of leucine and threonine; at the concentrations used isoleucine and valine do not affect leucine-specific regulation (H. Tu and M. Casadaban, unpublished) .
Genetic methods Cells were transformed and transfected with DNA by standard methods. E. coli cells were transformed by the CaCl2 method (24) or according to Morrison (25) . Bacterial strains were transfected with phage DNA as described by Messing (20) or Kunkel (26) . Yeast cells were transformed by the spheroplast method (27) . LEU2 gene induction and 3-galactosidase measurement The LEU2 promoters of the various LEU2-lacZ gene fusions were induced by transferring M12b transformants from repressed M63-minimal media into derepressed and repressed M63-minimal media. The cells were washed three times with water prior to transferring, and inoculated to a final OD6W of 0.050. The cultures were grown at 30°C to an OD6w of 0.400 to 0.500 and then spun down, resuspended and frozen at -70°C as described by Rose and Botstein (28) . ,-galactosidase liquid assays were carried out as outlined by Martinez-Arias et al. (6) . (3- (29) . Constructs were verified by DNA sequencing, restriction endonuclease analysis, or both. DNA was sequenced by the chemical base cleavage method (30) , and by either the single stranded M13 (31) or the double stranded dideoxy primer extension method (32 'All plasmids except plasmid pHT104 contain a single base change in the LEU2 promoter. The plasmid pHT104 contains the wildtype LEU2 promoter sequence and the first 39 basepairs of its coding sequence as shown in Figure IA . Each of the above plasmids were transformed into M 12b cells and assayed for their /3-galactosidase activities as described in Figure 2A . The base changes, their positions, and the restriction sites they form are as indicated in Figure IA .
Deletions into the UAS region Deletions from upstream of the UAS utilized the EcoRI site upstream of base -221 and were generated with BAL31 exonuclease ( Fig. 2A) . The deletions were constructed from the plasmid pHT141 ( The deleted region in the LEU2 promoter of pHT333 was replaced with spacer DNA (Fig. 2B) . The XbaI site that marks the deletions endpoints in pHT333 between bases -174 and -88 was cut, filled in and ligated to a 33 basepair XmnI, PvuIl fragment from pBR322 and a 39 basepair EcoRV fragment from lambda in two orientations. The pBR322 insertion formed pHT450; the lambda insertions formed pHT415 and pHT418.
Oligonucleotide-directed point changes Single base changes were introduced into the UAS region at bases -192, -191, and -178, using synthetic DNA (Fig. IA, Table  2 ) and the recombinant phage pMH14 following the method described by Kunkel (26) .
2RIGHTS and 2LEFIS palindromes
The UAS was replaced by two palindromes with homology to either the downstream (RIGHT) or upstream (LEFT) 'halves' of the UAS palindrome and flanking region (Fig. 3) . The 2LEFTS palindrome was obtained from pHT233 ( Fig. 2A ) and the 2RIGHTS palindrome from pHT141 ( Table 2 ). The 2RIGHTS and 2LEFTS palindromes were isolated as XbaI and EcoRI fragments, respectively, and inserted into their respective sites upstream of the LEU2 base -178 in pHT254.
Oligonucleotide UASs Palindromic sequences that contained various amounts of the UAS were inserted into UAS-deleted LEU2 promoters (Fig. 4) . The resulting oligonucleotides were synthesized with the following features: a SalI or XbaI restriction site adjacent to the 5' end, an Asp7l8 site at the 3' end, and interior bases matching the LEU2 region from base -189 to -188, -187, -185, -179, and -174. The oligonucleotides were converted into doublestranded molecules by the methods of Oliphant, Nussbaum, and Struhl (34) and Hill et. al. (35) . These molecules were cleaved with SailI or XbaI and ligated into the Sall or XbaI sites of pHT515, between the XhoI and SailI sites of pHT486, or into the XbaI site of pHT486 (Fig. 4) .
Multiple UASs in cis and in trans Multiple UASs were constructed from a 45 basepair UAS cassette ( Table 3 ). The cassette, constructed from pHT233 ( Fig. 2A) (Fig. IA, B) . This region contains all the sequences necessary for LEU2 activation and regulation (6) A. Martinez-Arias and M. Casadaban, unpublished) . Levels of activation and expression from this and subsequent LEU2-lacZ gene fusions were measured by assaying for ,B-galactosidase activity in the absence (derepressed) versus presence (repressed) of 2mM leucine and 2mM threonine for maximum leucine control.
Deletion analysis of the UAS The upstream endpoint of the UAS was mapped with deletions made on the plasmid pHT141 ( Fig. 2A) . Plasmid pHT141 is identical with pHT104 except for a base change at position -178, which creates an XbaI site (Fig. IA, see below) . The deletions were made with BAL31 exonuclease from the EcoRI site upstream of the -221 position of the promoter. Deletions to position -202 (pHT229, pHT233, pHT234, and pHT240) ( Fig.  2A) Fig. 2A . Deletion of the promoter region to base -173 (pHT 182) had no effect on regulation. In contrast, deletions extending to base -186 (pHT423, pHT459, and pHT468) decreased the regulation ratio from the wildtype levels to intermediate levels that ranged from a ratio of 2.2 to 2.8. Regulation was lost with the deletion into the GC-rich palindrome to base -189 (pHT470).
The two sets of deletions map a minimal and maximal UAS sequence necessary for activation and regulation. The endpoints of the sequence required for minimal UAS function are between bases -201 and -196 and between bases -189 and -187, inclusive (Fig. 2C) . The endpoints of the sequence required for maximal UAS function are between bases -201 and -196 and between bases -178 and -174, inclusive (Fig. 2C) . Both sequences contain the GC-rich palindrome important to UAS function, assymetrically positioned within the maximal sequence. Furthermore, a six basepair deletion within this GC-rich palindromeabolishes regulation whether the deletion is in a LEU2 promoter piece of 640 (31) or 221 (pHT123) basepairs. These results demonstrate the necessity of the GC-rich palindrome for even minimal UAS function.
Deletions downstream of the UAS Deletions were constructed downstream of the UAS from base -173 to determine if any other promoter sequences were required for activation (Fig. 2B) Spacer DNA from lambda and pBR322 was inserted at the junction of the deletion shown for the pHT333 promoter construct. The spacer DNA from lambda was inserted in both orientations, represented by pHT415 and pHT418; the spacer DNA from pBR322 was inserted in one orientation, represented by pHT450. C. The sequence necessary for minimal and maximal UAS function, as defined by deletion analysis, is shown. The dashed and solid enclosed regions refer to the deletion endpoints that were used to define the two sequences. All deletions were derived from the pHT141 plasmid, which contains the XbaI change at base -178, except for those plasmids marked with an 'a'; the latter were made starting with the pHT259 plasmid, which contains the Asp718 change at base -192.
2A) was restored with spacer DNA (Fig. 2B) . A 39 basepair lambda sequence and a 35 basepair pBR322 sequence were used for this purpose; neither sequence was homologous with the deleted LEU2 region or with the other sequences in the orientation tested. The 39 basepair lambda sequence was inserted in two orientations (pHT415 and pHT418), whereas the 35 basepair pBR322 sequence was inserted in only one (pHT450). Although expression was significantly higher for one lambda insert than the other, none of the inserts restored expression to wildtype levels.
Point mutants
To test the effect of mutations on the UAS, single base changes were introduced into the maximal UAS by site-directed mutagenesis ( Each of the three mutations affected UAS function differently. The Asp718 and BamHI mutations equally increased the symmetry within the GC-rich palindrome, but whereas the BamHI mutation reduced expression and regulation compared to the value of the control pHT104, the Asp718 mutation marginally increased expression and regulation . In contrast, the XbaI mutation reduced expression levels almost proportionately to the control values, with the net effect that regulation was not substantially altered.
Palindromic nature of the UAS The importance of the flanking regions to UAS function was addressed by extending the GC-rich palindrome to include either of its flanking sequences (Fig. 3) . The ability of the two extended palindromes to confer leucine-specific expression and regulation was measured by 3-galactosidase assays and the values werecompared to each other and to the appropriate controls. The 2RIGHTS construct increased derepressed and repressed expression by 60 % and 2 %, respectively, whereas the 2LEFTS construct decreased the levels 57% and 15 %, respectively, relative to the values of their positive control pHT233. The net effect was that regulation was increased by 60% for the 2RIGHTS construct and decreased by 48% for the 2LEFTS construct compared to control values.
Oligonucleotide UASs
The minimum sequence necessary for UAS function was determined by using palindromic oligonucleotides (Fig. 4) . Each palindrome had a center coincident with the GC-rich palindrome of the Asp718 mutation (Fig. IA) . Each palindrome was inserted upstream of base -125 of the UAS-deleted LEU2 promoters pHT515 and pHT486, using the polylinker sites upstream of the -125 position, and each was assayed for its ability to confer specific activation and regulation.
Palindromes that contained less than 10 basepairs of the region from -191 to -187 (pHT516 and pHT520) were unable to confer activation or regulation greater than the 0.49 value of their respective negative control (pHT515). In contrast, palindromes that contained 10 or more basepairs of the region from -191 to -174 were able to confer substantially higher levels. For the latter constructs, the regulation ratio ranged from 2.1 to 9.5, with the largest palindrome, pHT553, conferring the highest regulation value.
To determine whether both halves of the decanucleotide core were equally important to UAS function, two bases were changed in the 36-mer of pHT553 to form the two mutant constructs pHT496 and pHT499 (Fig. 4) (--) were compared to each other and to the UAS-deleted promoter fusion pHT254. All three promoter constructs contain the GC-rich palindrome of the wildtype UAS at their centers. The 2RIGHTS and 2LEFTS palindromes were constructed from the LEU2 promoter sequences of pHT141 and pHT233, respectively. The 2RIGHTS palindrome is symmetric for the bases -191 to -179 inclusive, in pHT141, and the 2LEFTS for the bases -212 to -192 inclusive, in pHT233. The center bases of these palindrome are asymmetric as in the LEU2 promoter. E, EcoRI; Xb, Xbal.
in cis and in trans to the LEU2-lacZ gene fusion on test plasmids (Table 3) . One to five elements were inserted tandemly in various orientations in cis and four multiples in uniform orientation in trans. The levels of activation and regulation conferred by each of the multiples in cis were determined directly from the construct, and those in trans from the recorder LEU2-lacZ fusion pHT259. This fusion contains a functional UAS that confers relatively high levels of expression, which should facilitate the detection of any trans effect. The levels of expression and regulation conferred by each of the multiples in cis were determined by f-galactosidase assays.
Increased levels of expression over those of a single wildtype element (pHT 141, pHT 182, and pHT346) were obtained in all cases as elements were added sequentially. However, derepressed and repressed expression levels did not increase linearly with the addition of each element. Thus, two (pHT249) and four (pHT421, pHT348) elements had higher levels of expression than either three (pHT345 and pHT354) or five (pHT351) elements. Also, the three inverted (pHT354) elements had the highest regulation ratio of all of the multiples. This mutant had a ratio of 9.4, while the others had ratios ranging from 6.7 to 7.8. The levels of activation and regulation in the presence or absence of the multiples in trans were tested by assaying cells transformed with the recorder fusion pHT259 and either the test plasmid pHT458 or its isogenic control plasmid YEp24. Decreased levels of expression and regulation were observed for pHT259 when multiple copies of the UAS were present. Relative to the control, cells cotransformed with pHT259 and pHT458 had derepressed and repressed expression levels that were reduced by 56% and 43%, respectively, and regulation reduced by 24%. DISCUSSION
The upstream activating sequence of the LEU2 gene was mapped with deletions ( Fig. 2) and clones of synthetic DNA (Fig. 4) . This sequence contained a core ten base-pair, GC-rich palindromic sequence, CCGGAACCGG, which is sufficient to confer minimal levels of activation and regulation. The core ten basepair region was made into two perfect palindromes by changing the middle AA sequence to TA (Asp718 mutation) and AT (BamHI mutation) ( Table 2 ). The TA change did not significantly change regulation, whereas the AT change reduced it by fifty percent. Also, the insertion of four, twelve and fourtythree basepairs between the center bases of the palindrome abolished activity of the UAS (data not shown). An additional non-palindromic 13 basepair, AT rich, sequence on the right (downstream) side was necessary for full levels of activation and regulation, as seen both with deletions ( Fig. 2) and with synthetic DNA clones (Fig. 4) . Inclusion of part of the 13 basepair sequence resulted in intermediate levels of regulation. The 13 basepair right flanking sequence was used to make an improved UAS by placing a second copy of it onto the left side, in the opposite orientation, of the 10 basepair core to create a 36 basepair palindromic sequence (Figs. 3 and 4) The LEU2 UAS region is homologous to sequences upstream of other leucine-regulated genes for branched chain amino acid synthesis, including the LEUJ (4, 15), LEU4 (4, 8) , ILV2 (4, 16) , and ILV5 (17) genes of Saccharomyces cerevisiae (Fig. 5) (19) and Candida maltosa (18) and to another fortuitous sequence from near the bacterial Cm gene of Tn9 (6) (Fig. 5) . The latter two of these sequences have been tested and shown to have leucine-regulated UAS activity in Saccharomyces cerevisiae.
The homology between these sequences is limited to the 10 basepair core region and not to the 13 basepair flanking region. It is possible that the flanking region is not used for its sequence but for its structure, such as in Z or bent DNA. Alternatively, the different flanking sequences may interact with other proteins, any of which may function with the UAS.
Interestingly, two regions with homology to the LEU2 UAS are present in several of the leucine-regulated genes, including the LEUI (4, 15), LEU4 (4, 8) , ILV2 (4, 16) (Fig. 5) . We have tested the effect of additional copies of the LEU2 UAS element placed in tandem upstream of the LEU2 promoter and have found that they result in increased activation and regulation. This effect has also been observed with other UAS elements, including those which bind GCN4 for general amino acid control (36) and GAL4 for galactose induction (37) , and with the UAS1 of the CYCI gene (38) . Larger increases were found for additions to even numbers than to odd numbers of the element in our constructs (Table 3) .
Multiple copies of the LEU2 UAS element were also tested in trans (Table 3) by placing four copies of the UAS on a high copy 2.u-plasmid (39) . A slight 24% reduction in the regulation level was observed. This reduction in regulation is consistent with a model that the UAS is used as a DNA-binding site for a positive control factor such as the product of LEU3. The limited ability of the trans UAS elements to titrate leucine-specific regulation may be due to a high concentration of the control factor in the cell, to a high number of sites in the cell to which the control factor has affinity for, or Genetic analysis of leucine-specific regulation indicates that regulation is dependent on the LEU3 product (2, 3, 4, 5) . Band shift assays show that fragments containing the LEU2 UAS are specifically retarded by factors present in a LEU3 crude cell extract but not in a leu3 null extract (3, 4) . This model has been further supported by Friden and Schimmel's (4) methylationinterference footprinting of the LEU2 element between bases -207 and -180, which includes the ten basepair core and six of the 13 basepair flanking sequence. In a LEU3 extract, strong protection was observed for the distal guanines in the decanucleotide and the guanines adjacent to the decanucleotide on both strands of the element, while weak protection was observed for the center two adenines and none observed for the remaining six bases of the UASL flank.
Deletion analysis and sequence substitution (Fig. 2B ) of the region downstream of the UAS indicates that high levels of activation require at least one other sequence region, which begins between basepairs -126 and -110, inclusive. Deletions of this region (pHT463, Fig. 2B ) drastically reduced expression but retained much of the regulation. The reduction was sequencespecific, as spacer DNAs used to replace a larger deleted area (-125 to base -89 in pHT333 to make pHT415, pHT418, and pHT450) were unable to restore wild type function. Within this region, mapping between bases -118 and -1 11, inclusive, is a TATA-like AT-rich sequence (TATFTTAA, Fig. IA) which was shown to bind with high affinity (Kd 10-9M) to the yeast TATA-binding factor TFIID (40) . This sequence is identical to the proposed TATA element sequence of the LEUI gene (15) . These TATA sequences fit the known criteria of a yeast TATA: they are downstream of the UAS (13, 14) and are between 50 to 120 basepairs upstream of the transcription initiation start sites (41, 42) .
In addition to leucine-specific control, many of the genes for branched-chain amino acid biosynthesis are also regulated by the GCN4 general amino acid control system (36) , including LEU4, ILV2, ILV3, and ILV5. Some genes, including LEUJ and LEU2, bThe number of UASs in tandem and the orientation of each UAS with respect to the LEU2 gene are shown; -and -indicates the wildtype and inverted orientation, respectively. All UASs in the cis configuration were derived by insertion of a 45 basepair UAS cassette at position -145 +/ 5 of the UASdeleted LEU2 promoter of pHT237 (Fig. 2B) .
cAssays for the cotransformants were performed with cells grown in media lacking tryptophan and uracil.
are regulated only by leucine, and others, including ILVI, only by general amino acid control. These two systems thereby interact to control the important branched-chain amino acid biosynthesis pathway, which converts pyruvate, a precursor to the tricarboxylic acid cycle, into.isoleucine, leucine, and valine (43 
